Affordable Access

Publisher Website

Copy Number Variants in German Patients with Schizophrenia

Public Library of Science
Publication Date
DOI: 10.1371/journal.pone.0064035
  • Research Article
  • Biology
  • Genetics
  • Human Genetics
  • Chromosomal Disorders
  • Chromosomal Deletions And Duplications
  • Genetic Association Studies
  • Genome-Wide Association Studies
  • Genetics Of Disease
  • Genomics
  • Genome Analysis Tools
  • Medicine
  • Clinical Genetics
  • Mental Health
  • Psychiatry
  • Schizophrenia
  • Biology
  • Medicine


Large rare copy number variants (CNVs) have been recognized as significant genetic risk factors for the development of schizophrenia (SCZ). However, due to their low frequency (1∶150 to 1∶1000) among patients, large sample sizes are needed to detect an association between specific CNVs and SCZ. So far, the majority of genome-wide CNV analyses have focused on reporting only CNVs that reached a significant P-value within the study cohort and merely confirmed the frequency of already-established risk-carrying CNVs. As a result, CNVs with a very low frequency that might be relevant for SCZ susceptibility are lost for secondary analyses. In this study, we provide a concise collection of high-quality CNVs in a large German sample consisting of 1,637 patients with SCZ or schizoaffective disorder and 1,627 controls. All individuals were genotyped on Illumina's BeadChips and putative CNVs were identified using QuantiSNP and PennCNV. Only those CNVs that were detected by both programs and spanned ≥30 consecutive SNPs were included in the data collection and downstream analyses (2,366 CNVs, 0.73 CNVs per individual). The genome-wide analysis did not reveal a specific association between a previously unknown CNV and SCZ. However, the group of CNVs previously reported to be associated with SCZ was more frequent in our patients than in the controls. The publication of our dataset will serve as a unique, easily accessible, high-quality CNV data collection for other research groups. The dataset could be useful for the identification of new disease-relevant CNVs that are currently overlooked due to their very low frequency and lack of power for their detection in individual studies.

There are no comments yet on this publication. Be the first to share your thoughts.